Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
14,851
Total Claims
$1.6M
Drug Cost
471
Beneficiaries
$3,340
Cost/Patient
Risk Score Breakdown 26/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-38%
Opioid rate vs peers
5.7% vs 9.2% avg
+364%
Cost per patient vs peers
$3,340 vs $719 avg
+145%
Brand preference vs peers
16.3% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
5.7%
Opioid Rate
847
Opioid Claims
$22K
Opioid Cost
8.0%
Long-Acting Rate
Brand vs Generic
Brand: 2,390 claims · $1.3M
Generic: 12,289 claims · $260K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 289 | $150K |
| Empagliflozin | 145 | $95K |
| Semaglutide | 70 | $93K |
| Insulin Degludec | 96 | $80K |
| Dulaglutide | 56 | $73K |
| Dapagliflozin Propanediol | 73 | $61K |
| Budesonide/Glycopyr/Formoterol | 73 | $60K |
| Rivaroxaban | 47 | $53K |
| Tirzepatide | 45 | $49K |
| Bictegrav/Emtricit/Tenofov Ala | 12 | $49K |
| Fluticasone/Umeclidin/Vilanter | 41 | $45K |
| Insulin Aspart | 81 | $36K |
| Umeclidinium Brm/Vilanterol Tr | 58 | $36K |
| Insulin Glargine,hum.Rec.Anlog | 65 | $28K |
| Cariprazine Hcl | 22 | $25K |
Prescribing Profile
Patient Profile
74
Avg Age
54%
Female
1.20
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About